(NASDAQ: SYBX) Synlogic's forecast annual revenue growth rate of 86.35% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Synlogic's revenue in 2024 is $3,371,000.On average, 1 Wall Street analysts forecast SYBX's revenue for 2024 to be $9,201,112, with the lowest SYBX revenue forecast at $9,201,112, and the highest SYBX revenue forecast at $9,201,112. On average, 1 Wall Street analysts forecast SYBX's revenue for 2025 to be $104,356,914, with the lowest SYBX revenue forecast at $104,356,914, and the highest SYBX revenue forecast at $104,356,914.
In 2026, SYBX is forecast to generate $264,968,727 in revenue, with the lowest revenue forecast at $264,968,727 and the highest revenue forecast at $264,968,727.